Mutational Impacts on the N and C Terminal Domains of the MUC5B Protein: A Transcriptomics and Structural Biology Study

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2023 Feb 6

PMID 36743039

Authors

Aamir Mehmood

Sadia Nawab

Yifan Jin

Aman Chandra Kaushik

Dong-Qing Wei

Affiliations

Soon will be listed here.

Abstract

Cholangiocarcinoma (CCA) involves various epithelial tumors historically linked with poor prognosis because of its aggressive sickness course, delayed diagnosis, and limited efficacy of typical chemotherapy in its advanced stages. In-depth molecular profiling has exposed a varied scenery of genomic alterations as CCA's oncogenic drivers. Previous studies have mainly focused on commonly occurring TP53 and KRAS alterations, but there is limited research conducted to explore other vital genes involved in CCA. We retrieved data from The Cancer Genome Atlas (TCGA) to hunt for additional CCA targets and plotted a mutational landscape, identifying key genes and their frequently expressed variants. Next, we performed a survival analysis for all of the top genes to shortlist the ones with better significance. Among those genes, we observed that MUC5B has the most significant -value of 0.0061. Finally, we chose two missense mutations at different positions in the vicinity of MUC5B N and C terminal domains. These mutations were further subjected to molecular dynamics (MD) simulation, which revealed noticeable impacts on the protein structure. Our study not only reveals one of the highly mutated genes with enhanced significance in CCA but also gives insights into the influence of its variants. We believe these findings are a good asset for understanding CCA from genomics and structural biology perspectives.

Citing Articles

In-silico structural and functional analysis of nonsynonymous single nucleotide polymorphisms in human gene.

Tondar A, Irfan M, Sanchez-Herrero S, Athar H, Haqqi A, Bepari A In Silico Pharmacol. 2025; 13(1):32.

PMID: 40018382 PMC: 11861814. DOI: 10.1007/s40203-025-00319-3.

Computer aided design of inhibitor molecules against Vpr protein from different HIV-1 subtypes.

Datta J, Majumder S, Giri K In Silico Pharmacol. 2025; 13(1):23.

PMID: 39931696 PMC: 11807045. DOI: 10.1007/s40203-025-00318-4.

Enhanced Disease Resistance Mechanism of the CmoAP2/ERF Transcription Factor in Pumpkin through Genetic Mutations.

Rashmi M, Murmu S, Singh M, Shankar R, Chaurasia A, Jha G ACS Omega. 2024; 9(47):46974-46985.

PMID: 39619556 PMC: 11603207. DOI: 10.1021/acsomega.4c06748.

Computational analysis of the deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in TYR gene impacting human tyrosinase protein and the protein stability.

Fan W, Ji H, Kakar M, Ahmed S, Alobaid H, Shakir Y PLoS One. 2024; 19(11):e0308927.

PMID: 39541331 PMC: 11563463. DOI: 10.1371/journal.pone.0308927.

In-silico study unveils potential phytocompounds in Andrographis paniculata against E6 protein of the high-risk HPV-16 subtype for cervical cancer therapy.

Islam M, Hossain M, Hasnat S, Shuvo M, Akter S, Maria M Sci Rep. 2024; 14(1):17182.

PMID: 39060289 PMC: 11282209. DOI: 10.1038/s41598-024-65112-2.

References

Mehmood A, Nawab S, Wang Y, Kaushik A, Wei D . Discovering potent inhibitors against the Mpro of the SARS-CoV-2. A medicinal chemistry approach. Comput Biol Med. 2022; 143:105235. PMC: 8789387. DOI: 10.1016/j.compbiomed.2022.105235. View

Gendler S, Spicer A . Epithelial mucin genes. Annu Rev Physiol. 1995; 57:607-34. DOI: 10.1146/annurev.ph.57.030195.003135. View

Dufosse J, Porchet N, Audie J, Guyonnet Duperat V, Laine A, Marrakchi S . Degenerate 87-base-pair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11p15. Biochem J. 1993; 293 ( Pt 2):329-37. PMC: 1134363. DOI: 10.1042/bj2930329. View

Verma M, Davidson E . Mucin genes: structure, expression and regulation. Glycoconj J. 1994; 11(3):172-9. DOI: 10.1007/BF00731215. View

Mehmood A, Khan M, Kaushik A, Khan A, Irfan M, Wei D . Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Associated With Pyrazinamide Resistance. Front Bioeng Biotechnol. 2020; 7:404. PMC: 6914729. DOI: 10.3389/fbioe.2019.00404. View

Porchet N, Nguyen V, Dufosse J, Audie J, Guyonnet-Duperat V, Gross M . Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Commun. 1991; 175(2):414-22. DOI: 10.1016/0006-291x(91)91580-6. View

Munoz-Garrido P, Rodrigues P . The jigsaw of dual hepatocellular-intrahepatic cholangiocarcinoma tumours. Nat Rev Gastroenterol Hepatol. 2019; 16(11):653-655. DOI: 10.1038/s41575-019-0185-z. View

Liu J, Lichtenberg T, Hoadley K, Poisson L, Lazar A, Cherniack A . An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018; 173(2):400-416.e11. PMC: 6066282. DOI: 10.1016/j.cell.2018.02.052. View

Bobek L, Tsai H, Biesbrock A, LeVine M . Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem. 1993; 268(27):20563-9. View

10.

Spolverato G, Kim Y, Alexandrescu S, Marques H, Lamelas J, Aldrighetti L . Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Ann Surg Oncol. 2015; 23(1):235-43. DOI: 10.1245/s10434-015-4642-9. View

11.

Song J, Wu S, Xia X, Wang Y, Fan Y, Yang Z . Cell adhesion-related gene somatic mutations are enriched in aggressive papillary thyroid microcarcinomas. J Transl Med. 2018; 16(1):269. PMC: 6167794. DOI: 10.1186/s12967-018-1642-0. View

12.

Groot Koerkamp B, Wiggers J, Allen P, Besselink M, Blumgart L, Busch O . Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. J Am Coll Surg. 2015; 221(6):1041-9. PMC: 4736142. DOI: 10.1016/j.jamcollsurg.2015.09.005. View

13.

Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag H . Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019; 71(1):104-114. DOI: 10.1016/j.jhep.2019.03.013. View

14.

Alabraba E, Joshi H, Bird N, Griffin R, Sturgess R, Stern N . Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged. Eur J Surg Oncol. 2019; 45(9):1660-1667. DOI: 10.1016/j.ejso.2019.04.002. View

15.

Sheik S, Sundararajan P, Hussain A, Sekar K . Ramachandran plot on the web. Bioinformatics. 2002; 18(11):1548-9. DOI: 10.1093/bioinformatics/18.11.1548. View

16.

Kim D, Chivian D, Baker D . Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 2004; 32(Web Server issue):W526-31. PMC: 441606. DOI: 10.1093/nar/gkh468. View

17.

Cambridge W, Fairfield C, Powell J, Harrison E, Soreide K, Wigmore S . Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma. Ann Surg. 2020; 273(2):240-250. DOI: 10.1097/SLA.0000000000003801. View

18.

Mehmood A, Kaushik A, Wang Q, Li C, Wei D . Bringing Structural Implications and Deep Learning-Based Drug Identification for Mutants. J Chem Inf Model. 2021; 61(2):571-586. DOI: 10.1021/acs.jcim.0c00488. View

19.

Wang Q, Mehmood A, Wang H, Xu Q, Xiong Y, Wei D . Computational Screening and Analysis of Lung Cancer Related Non-Synonymous Single Nucleotide Polymorphisms on the Human Kirsten Rat Sarcoma Gene. Molecules. 2019; 24(10). PMC: 6572712. DOI: 10.3390/molecules24101951. View

20.

Brunt E, Aishima S, Clavien P, Fowler K, Goodman Z, Gores G . cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. Hepatology. 2018; 68(1):113-126. PMC: 6340292. DOI: 10.1002/hep.29789. View